For the patients shown below, if Pr

For the patients shown below, if Product A had been available at the time you placed each of them onto their current treatment regimen would you have made a different treatment decision i.e. would you have used Product A instead of what they actually received?We’re specifically asking if you would have made a different decision, we are not asking if you would actively switch these patients from their current treatment to Product AClick here for a reminder of Product AClick here for a reminder about the assumptions we’ve asked you to considerDecision unchangedPatient would still have received the same treatment they didDecision changedPatient would have received Product A instead of what they actually receivedMoving on, we are now going to ask you about 3 slightly different variations of Product B. First of all, please review the following hypothetical data for Product B1.For comparison we are showing the profile for Product A alongside this.Based on the information provided, how motivated would you be to prescribe Product B1 in your patients with EGPA if it was available for you to use?For reference we are showing what you previously indicated for B1